February 14, 2025
The Obesity Working Group of the Spanish Society of Endocrinology and Nutrition (GOSEEN) conducts various awareness campaigns to address the growing global and national health challenges […]
February 13, 2025
A new dyslipidemia guideline from the American Association of Clinical Endocrinology (AACE) offers evidence-based recommendations for the use of newer drugs and focuses on outcomes that […]
February 13, 2025
More than a third of websites that advertise and sell compounded versions of popular drugs for diabetes and weight loss — such as Ozempic and Wegovy […]
February 12, 2025
Two professional obesity organizations have expressed concerns about the Lancet Commission’s new obesity definition, but its lead author says that much of the concern reflects misinterpretation. […]
February 10, 2025
High consumption of ultraprocessed foods (UPFs) is associated with obesity in early childhood, especially among young boys, a Canadian cohort study suggests. UPFs are defined as […]
February 10, 2025
Practiced for centuries as a ritual in many religions, intermittent fasting (IF) is rapidly growing in popularity as a weight loss and health-improvement tool. A 2024 […]
February 10, 2025
TOPLINE: COVID-19 vaccination is associated with a reduced risk for hyperthyroidism in the initial months postimmunization, but it is associated with an increased risk for hypothyroidism […]
February 7, 2025
TOPLINE: Romosozumab for 12 months followed by alendronate for 24 months leads to greater improvements in lumbar spine bone density and trabecular bone scores than alendronate […]
February 6, 2025
The US Food and Drug Administration (FDA) is cautioning patients and caregivers about the potential for not receiving blood glucose level alerts from diabetes-related smartphone devices […]